您的位置: 首页 > 农业专利 > 详情页

PHARMACEUTICAL FORMULATION IN THE FORM OF BILAYERED TABLETS COMPRISING HMG-COA REDUCTASE INHIBITOR AND IRBESARTAN
专利权人:
HANMI SCIENCE CO.; LTD.
发明人:
KIM, YONG IL,NA, YOUNG JUN,KIM, MIN JUNG,KIM, YOUNG-HUN,PARK, JAE HYUN,WOO, JONG SOO
申请号:
SG2012087227
公开号:
SG185778A1
申请日:
2011.05.13
申请国别(地区):
SG
年份:
2013
代理人:
摘要:
Provided is a pharmaceutical formulation in the form of bilayered tablets consisting of a first layer containing irbesartan or pharmaceutically acceptable salts thereof and a second layer containing an HMG-CoA reductase inhibitor and a basic additive, which can improve the dissolution rate and stability of irbesartan and an HMG-CoA reductase inhibitor to enhance the bioavailability of the drug compared to conventional complex formulations and to minimize the generation of the related compounds, thereby being effectively used as a stable and superior therapeutic agent for hypertension and hypercholesterolemia.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充